- Company
- Newly approved JAK inhibitor Rinvoq to apply for reimburseme
- by Eo, Yun-Ho Jun 15, 2020 06:17am
- The fourth Janus kinase (JAK) inhibitor in Korea Rinvoq is swiftly pursuing the healthcare reimbursement listing. According to the pharmaceutical industry sources, AbbVie Korea submitted the healthcare reimbursement application for Rinvoq (upadacitinib) on June 4, immediately after receiving the market approval. Considering Pfizer’
- Company
- Takeda Korea, announces massive ERP
- by An, Kyung-Jin Jun 15, 2020 06:16am
- The aftermath for the sale of the Takeda’s business division began. According to the industry on the 12th, Takeda Korea held a town hall meeting for all employees this morning, and had a time to share information related to the sale of the business division. This is a follow-up procedure following the formalization of a contract to sell
- Company
- The KDPU joined the memorial against racism
- by An, Kyung-Jin Jun 15, 2020 06:16am
- The domestic pharmaceutical industry gathered to honor memory of George Floyd, a black man who died from the abuse of public power by the American police. On the afternoon of the 11th, Lundbeck Korea branch of the Koea Democratic Pharmaceutical Union held a memorial performance for George Floyd during a protest rally in front of the Lundb
- Company
- MSD takes a first step to New Normal granting a free day off
- by Eo, Yun-Ho Jun 12, 2020 06:14am
- Apparently, MSD Korea is leading the age of the ‘New Normal’ with a new project. Due to the COVID-19 pandemic, companies have been experiencing small and big unavoidable changes in the working environment. Pharmaceutical and bio industries took actions fast and tried out new working styles, like working from home, flexible working ho
- Company
- KARS and Galderma to run first rosacea campaign in Korea
- by Eo, Yun-Ho Jun 12, 2020 06:12am
- Korean Acne and Rosacea Society (KARS) and Galderma Korea are conducting a campaign to raise awareness in early symptoms and diagnosis of rosacea. From May 6, Galderma Korea has been disseminating rosacea diagnostic checklist, developed with the board of KARS, to private dermatology clinics for the visiting patients and doctors to use.
- Company
- Prompt review is urgent for COVID-19 treatment
- by Nho, Byung Chul Jun 12, 2020 06:11am
- It is noteworthy that industry consensus is demanding a fast track clinical trial approval process for autoimmune therapies that have been proven to be safe, as countries around the world are eager to develop vaccines and treatments related to the COVID-19 infection pandemic. The MFDS is also actively sympathizing with this situation, and
- Company
- Online seminar for Physicians & pharmacists is approaching
- by Eo, Yun-Ho Jun 11, 2020 06:23am
- The trend of physicians-pharmacists online seminar (webinar), which is attracting attention due to the spread of COVID-19, is rapidly changing from 2D to 3D, and from one person to multiple. Online seminars are regarded as the advantages of non-face-to-face, COVID-19 accessibility and re-viewing regardless of location/time, and have establ
- Company
- A contract for all items with Leo/Baekje has been signed
- by Jun 11, 2020 06:22am
- A contract for exclusive sales of all items with a global pharmaceutical company and a domestic drug distributor has been concluded. On the 8th, Leo-Pharma (CEO Jung-beom Shin) and Baekje (CEO Dong Gu Kim) announced on the 9th that they have signed a distributor service contract for Leo-Pharma’s dermatology products at the headquarters of
- Company
- Surveillance or global standard? Dispute over SAP by MSD
- by Jun 11, 2020 06:22am
- The employees of MSD Korea are strongly opposing against the management planning to implement tightened self-assurance program (SAP) guideline. The company’s sales department is infuriated with the Korean management adhering to the global standard, regardless of the employees constantly demanding for flexible amendment. According to the
- Company
- HPV vaccine Gardasil9 eligible age to extend up to 45
- by Eo, Yun-Ho Jun 10, 2020 06:12am
- The vaccination eligible age for the human papillomavirus (HPV) vaccine Gardasil9 would be extended in Korea as well. Pharmaceutical industry sources reported, MSD has submitted an indication extension application to Ministry of Food and Drug Safety (MFDS) to vaccinate both female and male in age 27 to 45. The approval may be cleared in
